Immunobiology and treatment of cutaneous T-cell lymphoma

被引:0
|
作者
Goel, Rishi R. [1 ,2 ]
Rook, Alain H. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Univ Penn, Inst Immunol & Immune Hlth I3H, Perelman Sch Med, Philadelphia, PA USA
关键词
Cutaneous T cell lymphoma; CTCL; mycosis fungoides; Sezary syndrome; cutaneous oncology; immunotherapy; CHIMERIC ANTIGEN RECEPTOR; FIBROBLAST ACTIVATION PROTEIN; TUMOR BLOOD-VESSELS; ANTITUMOR-ACTIVITY; CHECKPOINT BLOCKADE; PHASE-I; ALPHA-V-BETA-3; INTEGRIN; STROMAL FIBROBLASTS; MONOCLONAL-ANTIBODY; ESTABLISHED TUMORS;
D O I
10.1080/1744666X.2024.2326035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IntroductionPrimary cutaneous T cell lymphomas (CTCL) are a heterogenous group of non-Hodgkin lymphomas derived from skin-homing T cells. These include mycosis fungoides and its leukemic variant Sezary syndrome, as well as the CD30+ lymphoproliferative disorders.Areas CoveredIn this review, we provide a summary of the current literature on CTCL, with a focus on the immunopathogenesis and treatment of mycosis fungoides and Sezary syndrome.Expert OpinionRecent advances in immunology have provided new insights into the biology of malignant T cells. This in turn has led to the development of new therapies that modulate the immune system to facilitate tumor clearance or target specific aspects of tumor biology.
引用
收藏
页码:985 / 996
页数:12
相关论文
共 50 条
  • [1] TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    BUNN, PA
    CARNEY, DN
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1980, 6 (05): : 383 - 387
  • [2] TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    ZACKHEIM, HS
    SEMINARS IN DERMATOLOGY, 1994, 13 (03): : 207 - 215
  • [3] TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    VONDERHEID, EC
    MICAILY, B
    DERMATOLOGIC CLINICS, 1985, 3 (04) : 673 - 687
  • [4] Bexarotene in the treatment of cutaneous T-cell lymphoma
    Querfeldt, Christiane
    Nagelli, Lakshmi V.
    Rosen, Steven T.
    Kuzel, Timothy M.
    Guitart, Joan
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (07) : 907 - 915
  • [5] Update on treatment of cutaneous T-cell lymphoma
    Gardner, Jennifer M.
    Evans, Katherine G.
    Musiek, Amy
    Rook, Alain H.
    Kim, Ellen J.
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (02) : 131 - 137
  • [6] CISPLATIN TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    WITMAN, G
    CADMAN, E
    BRAVERMAN, I
    CANCER TREATMENT REPORTS, 1981, 65 (9-10): : 920 - 920
  • [7] Alitretinoin in the treatment of cutaneous T-cell lymphoma
    Kaemmerer, Till
    Stadler, Pia-Charlotte
    Frommherz, Leonie Helene
    Guertler, Anne
    French, Lars Einar
    Reinholz, Markus
    CANCER MEDICINE, 2021, 10 (20): : 7071 - 7078
  • [8] Forodesine in the treatment of cutaneous T-cell lymphoma
    Lewis, Daniel J.
    Duvic, Madeleine
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (06) : 771 - 775
  • [9] Acitretin for the treatment of cutaneous T-cell lymphoma
    Cheeley, Justin
    Sahn, Rachel E.
    DeLong, Laura K.
    Parker, Sareeta R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (02) : 247 - 254
  • [10] Treatment of cutaneous T-cell lymphoma with retinoids
    Zhang, Chunlei
    Duvic, Madeleine
    DERMATOLOGIC THERAPY, 2006, 19 (05) : 264 - 271